Literature DB >> 14973953

Multicomponent fortified human milk for promoting growth in preterm infants.

C A Kuschel1, J E Harding.   

Abstract

BACKGROUND: For term infants, human milk provides adequate nutrition to facilitate growth, as well as potential beneficial effects on immunity and the maternal-infant emotional state. However, the role of human milk in premature infants is less well defined as it contains insufficient quantities of some nutrients to meet the estimated needs of the infant. Observational studies have suggested that infants fed formula have a higher rate of growth than infants who are breast fed. However, there are potential short term and long term benefits from human milk. Commercially-produced multicomponent fortifiers provide additional nutrients to supplement human milk (in the form of protein, calcium, phosphate, and carbohydrate, as well as vitamins and trace minerals).
OBJECTIVES: The main objective was to determine if addition of multicomponent nutritional supplements to human milk leads to improved growth, bone metabolism and neurodevelopmental outcomes without significant adverse effects in premature infants. SEARCH STRATEGY: Searches were made of the Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library, Issue 2, 3003), MEDLINE (searched August 29, 2003), previous reviews including cross references, abstracts, conferences and symposia proceedings, expert informants, journal handsearching mainly in the English language. SELECTION CRITERIA: All trials utilising random or quasi-random allocation to supplementation of human milk with multiple nutrients or no supplementation in premature infants within a nursery setting were eligible. DATA COLLECTION AND ANALYSIS: Data were extracted using the standard methods of the Cochrane Collaboration and its Neonatal Review Group, with separate evaluation of trial quality and data extraction by each author and synthesis of data using relative risk and weighted mean difference. MAIN
RESULTS: Supplementation of human milk with multicomponent fortifiers is associated with short term increases in weight gain, linear and head growth. There is no effect on serum alkaline phosphatase levels; it is not clear if there is an effect on bone mineral content. Nitrogen retention and blood urea levels appear to be increased. There are insufficient data to evaluate long term neurodevelopmental and growth outcomes, although there appears to be no effect on growth beyond one year of life. Use of multicomponent fortifiers does not appear to be associated with adverse effects, although the total number of infants studied and the large amount of missing data reduces confidence in this conclusion. Blood urea levels are increased and blood pH levels minimally decreased, but the clinical significance of this is uncertain. REVIEWER'S
CONCLUSIONS: Multicomponent fortification of human milk is associated with short-term improvements in weight gain, linear and head growth. Despite the absence of evidence of long-term benefit and insufficient evidence to be reassured that there are no deleterious effects, it is unlikely that further studies evaluating fortification of human milk versus no supplementation will be performed. Further research should be directed toward comparisons between different proprietary preparations and evaluating both short-term and long-term outcomes in search of the "optimal" composition of fortifiers.

Entities:  

Mesh:

Year:  2004        PMID: 14973953     DOI: 10.1002/14651858.CD000343.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  32 in total

Review 1.  Working group reports: evaluation of the evidence to support practice guidelines for nutritional care of preterm infants-the Pre-B Project.

Authors:  Daniel J Raiten; Alison L Steiber; Susan E Carlson; Ian Griffin; Diane Anderson; William W Hay; Sandra Robins; Josef Neu; Michael K Georgieff; Sharon Groh-Wargo; Tanis R Fenton
Journal:  Am J Clin Nutr       Date:  2016-01-20       Impact factor: 7.045

2.  Excess vitamin intake: An unrecognized risk factor for obesity.

Authors:  Shi-Sheng Zhou; Yiming Zhou
Journal:  World J Diabetes       Date:  2014-02-15

3.  Supplemented vs. unsupplemented human milk on bone mineralization in very low birth weight preterm infants: a randomized clinical trial.

Authors:  P R Einloft; P C R Garcia; J P Piva; R Schneider; H H Fiori; R M Fiori
Journal:  Osteoporos Int       Date:  2015-05-14       Impact factor: 4.507

4.  Factors associated with infant feeding of human milk at discharge from neonatal intensive care: Cross-sectional analysis of nurse survey and infant outcomes data.

Authors:  Sunny G Hallowell; Jeannette A Rogowski; Diane L Spatz; Alexandra L Hanlon; Michael Kenny; Eileen T Lake
Journal:  Int J Nurs Stud       Date:  2015-10-09       Impact factor: 5.837

5.  Effect of Different Human Milk Fortifiers on Milk Composition and Growth.

Authors:  Sumandeep Kaur; Sunita Sharma; Kanya Mukhopadhyay; Savita Verma
Journal:  Indian J Pediatr       Date:  2016-05-20       Impact factor: 1.967

Review 6.  Feeding practices and necrotizing enterocolitis.

Authors:  Manimaran Ramani; Namasivayam Ambalavanan
Journal:  Clin Perinatol       Date:  2013-01-17       Impact factor: 3.430

7.  The value of routine evaluation of gastric residuals in very low birth weight infants.

Authors:  R M Torrazza; L A Parker; Y Li; E Talaga; J Shuster; J Neu
Journal:  J Perinatol       Date:  2014-08-28       Impact factor: 2.521

Review 8.  Evidence-based feeding strategies before and after the development of necrotizing enterocolitis.

Authors:  Misty Good; Chhinder P Sodhi; David J Hackam
Journal:  Expert Rev Clin Immunol       Date:  2014-06-05       Impact factor: 4.473

Review 9.  Human milk for the premature infant.

Authors:  Mark A Underwood
Journal:  Pediatr Clin North Am       Date:  2012-10-18       Impact factor: 3.278

10.  Metabolic Bone Disease in preterm newborn: an update on nutritional issues.

Authors:  Valentina Bozzetti; Paolo Tagliabue
Journal:  Ital J Pediatr       Date:  2009-07-14       Impact factor: 2.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.